Compare Healthy Life with Similar Stocks
Total Returns (Price + Dividend) 
Healthy Life for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Healthy Life Agritec Ltd?
The next results date for Healthy Life Agritec Ltd is scheduled for 14 February 2026....
Read full news articleIs Healthy Life overvalued or undervalued?
As of 18 November 2025, the valuation grade for Healthy Life has moved from very attractive to expensive. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.90, an EV to EBITDA of 16.07, and a ROCE of 10.96%. In comparison to its peers, Healthy Life's PE ratio is significantly lower than Hindustan Unilever's 53.39 and Nestle India's 81.48, both of which are categorized as very expensive. Despite this, Healthy Life's current valuation does not justify its price, especially given its recent stock performance, which has seen a drastic decline of 72.29% year-to-date, contrasting sharply with the Sensex's 8.36% gain in the same period....
Read full news articleHow has been the historical performance of Healthy Life?
Answer: The historical performance of Healthy Life shows significant growth over the years, particularly in net sales and profitability. Breakdown: Healthy Life's net sales have increased from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 33.96 Cr in Mar'22 to 171.87 Cr in Mar'25. The company's total expenditure also grew, from 32.78 Cr in Mar'22 to 166.98 Cr in Mar'25, but the operating profit (PBDIT) improved from 1.18 Cr to 4.89 Cr during the same period, indicating enhanced operational efficiency. Profit before tax rose from 1.12 Cr in Mar'22 to 4.35 Cr in Mar'25, while profit after tax increased from 0.83 Cr to 3.26 Cr, showcasing a consistent improvement in profitability. The earnings per share (EPS) fluctuated, reaching 0.83 in Mar'25, down from 1.14 in Mar'24. On the balance sheet, total assets grew...
Read full news article Announcements 
Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 31St December 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015.
10-Feb-2026 | Source : BSEHealthy Life Agritec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve 1) Consider and approve Unaudited Standalone and consolidated Financial Results of the Company for the Quarter ended 31st December 2025. 2) Consider any other matter with the permission of the Chair .
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
21-Jan-2026 | Source : BSEPlease find enclosed herewith certificate under regulation 74(5) of SEBI(DP) Regulations 2018
Closure of Trading Window
26-Dec-2025 | Source : BSEIntimation of closure of trading window pursuant to SEBI PIT Regulation 2015
Corporate Actions 
14 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
Healthy Life Agritec Ltd has announced 1:1 rights issue, ex-date: 26 Sep 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.4%)
Cronosglobal Investment & Holding Private Limited (18.17%)
Santosh Ghosh (2.9%)
60.49%
Quarterly Results Snapshot (Standalone) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 7.47% vs 13.20% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 4.35% vs 17.95% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.50% vs -4.67% in Mar 2025
Growth in half year ended Sep 2025 is -22.49% vs 78.63% in Mar 2025
Nine Monthly Results Snapshot (Consolidated) - Jun'25
YoY Growth in nine months ended Jun 2025 is 2.31% vs 57.38% in Jun 2025
YoY Growth in nine months ended Jun 2025 is 22.50% vs 58.73% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 29.27% vs 23.31% in Mar 2024
YoY Growth in year ended Mar 2025 is 29.88% vs 66.23% in Mar 2024






